| Name |
Number of Publications
|
Most Recent Publication
|
Publications by All Authors
|
Concept Score
|
Why?
|
|---|
| Prenatal Diagnosis | 47 | 2026 | 612 | 9.950 |
Why?
|
| Genetic Diseases, Inborn | 13 | 2025 | 468 | 3.300 |
Why?
|
| Genetic Testing | 16 | 2025 | 1106 | 3.230 |
Why?
|
| Pregnancy | 92 | 2026 | 7512 | 3.090 |
Why?
|
| Genetic Counseling | 13 | 2025 | 237 | 2.700 |
Why?
|
| Trophoblasts | 10 | 2026 | 113 | 2.300 |
Why?
|
| Adaptor Proteins, Signal Transducing | 8 | 2026 | 619 | 2.300 |
Why?
|
| Amniocentesis | 7 | 2024 | 77 | 2.240 |
Why?
|
| Chromosome Disorders | 11 | 2019 | 316 | 1.900 |
Why?
|
| Cell-Free Nucleic Acids | 5 | 2026 | 57 | 1.830 |
Why?
|
| Oocytes | 6 | 2025 | 283 | 1.800 |
Why?
|
| Hydatidiform Mole | 9 | 2018 | 19 | 1.730 |
Why?
|
| DNA Methylation | 12 | 2025 | 1077 | 1.690 |
Why?
|
| Embryonic Development | 6 | 2026 | 200 | 1.600 |
Why?
|
| Exome | 5 | 2022 | 1061 | 1.570 |
Why?
|
| Female | 124 | 2026 | 70963 | 1.430 |
Why?
|
| Genomic Imprinting | 6 | 2021 | 121 | 1.410 |
Why?
|
| X Chromosome | 13 | 2023 | 327 | 1.410 |
Why?
|
| Fetus | 14 | 2025 | 568 | 1.400 |
Why?
|
| Chorionic Villi Sampling | 7 | 2026 | 44 | 1.390 |
Why?
|
| Congenital Abnormalities | 6 | 2026 | 330 | 1.340 |
Why?
|
| Ultrasonography, Prenatal | 10 | 2022 | 986 | 1.280 |
Why?
|
| Rett Syndrome | 11 | 2006 | 231 | 1.250 |
Why?
|
| Pre-Eclampsia | 2 | 2022 | 226 | 1.240 |
Why?
|
| Genomics | 4 | 2024 | 1621 | 1.220 |
Why?
|
| Single-Cell Analysis | 7 | 2026 | 350 | 1.180 |
Why?
|
| Fertilization in Vitro | 2 | 2020 | 155 | 1.150 |
Why?
|
| Aneuploidy | 9 | 2026 | 138 | 1.120 |
Why?
|
| Genetic Carrier Screening | 2 | 2019 | 67 | 1.110 |
Why?
|
| Stillbirth | 3 | 2025 | 95 | 1.110 |
Why?
|
| Amniotic Fluid | 9 | 2026 | 147 | 1.090 |
Why?
|
| Pregnancy Trimester, First | 6 | 2022 | 117 | 1.080 |
Why?
|
| Incidental Findings | 3 | 2020 | 122 | 1.080 |
Why?
|
| Uterine Neoplasms | 6 | 2013 | 100 | 1.060 |
Why?
|
| Pregnancy Complications | 6 | 2022 | 567 | 1.060 |
Why?
|
| Nucleic Acid Amplification Techniques | 3 | 2026 | 69 | 1.040 |
Why?
|
| Mutation | 17 | 2022 | 6099 | 1.030 |
Why?
|
| Humans | 136 | 2026 | 131163 | 1.030 |
Why?
|
| Transcriptome | 2 | 2025 | 1103 | 1.020 |
Why?
|
| Zygote | 3 | 2025 | 28 | 1.020 |
Why?
|
| Gestational Age | 6 | 2024 | 1224 | 0.960 |
Why?
|
| Nervous System Malformations | 3 | 2022 | 135 | 0.950 |
Why?
|
| Proteins | 5 | 2023 | 1006 | 0.950 |
Why?
|
| Comparative Genomic Hybridization | 7 | 2016 | 566 | 0.940 |
Why?
|
| Focal Dermal Hypoplasia | 6 | 2014 | 17 | 0.940 |
Why?
|
| Chromosome Aberrations | 10 | 2018 | 573 | 0.930 |
Why?
|
| Fetal Death | 2 | 2025 | 115 | 0.920 |
Why?
|
| DNA Copy Number Variations | 10 | 2019 | 1029 | 0.920 |
Why?
|
| Sex Chromosome Aberrations | 5 | 2026 | 61 | 0.910 |
Why?
|
| Genome, Human | 5 | 2026 | 1321 | 0.870 |
Why?
|
| Prenatal Care | 6 | 2023 | 345 | 0.810 |
Why?
|
| High-Throughput Nucleotide Sequencing | 8 | 2026 | 889 | 0.800 |
Why?
|
| Human Embryonic Stem Cells | 1 | 2023 | 20 | 0.790 |
Why?
|
| Turner Syndrome | 2 | 2023 | 44 | 0.780 |
Why?
|
| Phenotype | 17 | 2024 | 4497 | 0.770 |
Why?
|
| Pregnancy Proteins | 1 | 2023 | 17 | 0.760 |
Why?
|
| Microarray Analysis | 8 | 2023 | 222 | 0.760 |
Why?
|
| Apoptosis Regulatory Proteins | 3 | 2020 | 157 | 0.760 |
Why?
|
| Histone Demethylases | 1 | 2023 | 41 | 0.750 |
Why?
|
| Sequence Analysis, DNA | 9 | 2020 | 1692 | 0.750 |
Why?
|
| Karyopherins | 1 | 2023 | 35 | 0.750 |
Why?
|
| Down Syndrome | 4 | 2023 | 233 | 0.740 |
Why?
|
| Fetal Diseases | 7 | 2015 | 440 | 0.740 |
Why?
|
| Preimplantation Diagnosis | 2 | 2020 | 29 | 0.710 |
Why?
|
| Hypertension, Pregnancy-Induced | 2 | 2022 | 80 | 0.700 |
Why?
|
| Oligonucleotide Array Sequence Analysis | 5 | 2012 | 992 | 0.690 |
Why?
|
| Metabolomics | 1 | 2025 | 501 | 0.680 |
Why?
|
| Beckwith-Wiedemann Syndrome | 1 | 2021 | 22 | 0.670 |
Why?
|
| Databases, Genetic | 2 | 2024 | 504 | 0.660 |
Why?
|
| Gene Deletion | 5 | 2018 | 767 | 0.640 |
Why?
|
| Genetic Linkage | 8 | 2010 | 461 | 0.640 |
Why?
|
| Chromosomal Proteins, Non-Histone | 7 | 2011 | 209 | 0.640 |
Why?
|
| Epigenesis, Genetic | 4 | 2025 | 757 | 0.630 |
Why?
|
| Germ Cells | 1 | 2021 | 201 | 0.630 |
Why?
|
| Genes, Lethal | 5 | 2024 | 71 | 0.570 |
Why?
|
| Karyotyping | 5 | 2024 | 308 | 0.560 |
Why?
|
| Diet, Protein-Restricted | 2 | 2017 | 71 | 0.560 |
Why?
|
| Cellular Reprogramming | 2 | 2017 | 129 | 0.550 |
Why?
|
| Maternal Exposure | 1 | 2019 | 150 | 0.550 |
Why?
|
| Preconception Care | 1 | 2018 | 15 | 0.540 |
Why?
|
| Gene Expression Regulation, Developmental | 7 | 2026 | 950 | 0.540 |
Why?
|
| Mice | 20 | 2026 | 18301 | 0.540 |
Why?
|
| Reproductive Medicine | 1 | 2018 | 20 | 0.530 |
Why?
|
| Prenatal Exposure Delayed Effects | 1 | 2019 | 237 | 0.510 |
Why?
|
| White Matter | 1 | 2019 | 219 | 0.510 |
Why?
|
| Retinal Diseases | 3 | 2012 | 142 | 0.500 |
Why?
|
| Rh-Hr Blood-Group System | 4 | 1999 | 14 | 0.500 |
Why?
|
| Microphthalmos | 3 | 2002 | 54 | 0.490 |
Why?
|
| Gene Dosage | 7 | 2012 | 435 | 0.490 |
Why?
|
| Physicians | 1 | 2023 | 635 | 0.490 |
Why?
|
| DNA | 11 | 2021 | 1399 | 0.480 |
Why?
|
| Cerebral Cortex | 1 | 2019 | 445 | 0.480 |
Why?
|
| DNA Mutational Analysis | 13 | 2014 | 775 | 0.470 |
Why?
|
| Precision Medicine | 1 | 2019 | 388 | 0.470 |
Why?
|
| Patient Participation | 1 | 2019 | 254 | 0.470 |
Why?
|
| Multiprotein Complexes | 1 | 2017 | 195 | 0.470 |
Why?
|
| Cerebellum | 2 | 2019 | 441 | 0.460 |
Why?
|
| Genome-Wide Association Study | 5 | 2022 | 1833 | 0.450 |
Why?
|
| Pregnancy Outcome | 4 | 2024 | 623 | 0.450 |
Why?
|
| Genes | 3 | 2014 | 308 | 0.450 |
Why?
|
| Retrospective Studies | 15 | 2026 | 17753 | 0.440 |
Why?
|
| Placenta | 6 | 2026 | 504 | 0.440 |
Why?
|
| Membrane Proteins | 4 | 2012 | 1590 | 0.430 |
Why?
|
| Fertility | 1 | 2017 | 260 | 0.430 |
Why?
|
| Animals | 26 | 2026 | 33912 | 0.430 |
Why?
|
| Stress, Psychological | 1 | 2019 | 536 | 0.430 |
Why?
|
| Supreme Court Decisions | 1 | 2014 | 16 | 0.420 |
Why?
|
| Patents as Topic | 1 | 2014 | 18 | 0.420 |
Why?
|
| Polymerase Chain Reaction | 9 | 2010 | 1447 | 0.420 |
Why?
|
| Anxiety | 2 | 2022 | 1014 | 0.420 |
Why?
|
| Lipoma | 1 | 2014 | 24 | 0.420 |
Why?
|
| Nevus | 1 | 2014 | 34 | 0.420 |
Why?
|
| Adult | 32 | 2026 | 31282 | 0.420 |
Why?
|
| Circadian Rhythm | 1 | 2017 | 327 | 0.410 |
Why?
|
| Syndrome | 10 | 2009 | 1155 | 0.410 |
Why?
|
| Gene Expression Profiling | 6 | 2026 | 1801 | 0.400 |
Why?
|
| Musculoskeletal Abnormalities | 1 | 2014 | 67 | 0.400 |
Why?
|
| Nerve Tissue Proteins | 1 | 2019 | 1075 | 0.400 |
Why?
|
| Lyases | 3 | 2002 | 12 | 0.400 |
Why?
|
| YY1 Transcription Factor | 1 | 2013 | 17 | 0.400 |
Why?
|
| Skin Abnormalities | 3 | 2002 | 34 | 0.400 |
Why?
|
| Sleep | 1 | 2017 | 381 | 0.390 |
Why?
|
| Patient Rights | 1 | 2013 | 49 | 0.390 |
Why?
|
| Genetic Diseases, X-Linked | 3 | 2009 | 81 | 0.390 |
Why?
|
| GTPase-Activating Proteins | 2 | 2005 | 83 | 0.390 |
Why?
|
| Practice Guidelines as Topic | 1 | 2020 | 1295 | 0.390 |
Why?
|
| Vascular Malformations | 1 | 2014 | 103 | 0.380 |
Why?
|
| In Situ Hybridization, Fluorescence | 8 | 2017 | 743 | 0.380 |
Why?
|
| Mosaicism | 5 | 2022 | 248 | 0.380 |
Why?
|
| Developmental Disabilities | 2 | 2009 | 781 | 0.380 |
Why?
|
| Exons | 6 | 2009 | 759 | 0.380 |
Why?
|
| Phosphatidylinositol 3-Kinases | 1 | 2014 | 335 | 0.370 |
Why?
|
| Infant, Newborn | 15 | 2023 | 8635 | 0.370 |
Why?
|
| Methyl-CpG-Binding Protein 2 | 7 | 2006 | 286 | 0.350 |
Why?
|
| Energy Metabolism | 1 | 2017 | 804 | 0.350 |
Why?
|
| Blastocyst | 4 | 2020 | 73 | 0.340 |
Why?
|
| Base Sequence | 11 | 2013 | 2730 | 0.340 |
Why?
|
| Aicardi Syndrome | 2 | 2025 | 17 | 0.320 |
Why?
|
| Fetal Blood | 3 | 1996 | 176 | 0.320 |
Why?
|
| Embryo, Mammalian | 3 | 2022 | 403 | 0.310 |
Why?
|
| Microtubule Proteins | 2 | 2001 | 28 | 0.310 |
Why?
|
| Ornithine Carbamoyltransferase Deficiency Disease | 1 | 2010 | 42 | 0.310 |
Why?
|
| Microfilament Proteins | 2 | 2019 | 269 | 0.310 |
Why?
|
| Male | 35 | 2025 | 64957 | 0.310 |
Why?
|
| Abortion, Habitual | 2 | 2014 | 15 | 0.310 |
Why?
|
| Transcription Factors | 6 | 2023 | 2406 | 0.300 |
Why?
|
| Abnormalities, Multiple | 6 | 2019 | 963 | 0.300 |
Why?
|
| Genes, Dominant | 4 | 2002 | 242 | 0.300 |
Why?
|
| Genetic Markers | 3 | 2019 | 587 | 0.300 |
Why?
|
| Disease Models, Animal | 7 | 2024 | 4697 | 0.290 |
Why?
|
| Chromosomes, Human, X | 3 | 2017 | 155 | 0.290 |
Why?
|
| Polymorphism, Single Nucleotide | 5 | 2026 | 2833 | 0.290 |
Why?
|
| Chorionic Villi | 2 | 2026 | 20 | 0.290 |
Why?
|
| DNA-Binding Proteins | 7 | 2003 | 1939 | 0.290 |
Why?
|
| Agenesis of Corpus Callosum | 2 | 2007 | 49 | 0.290 |
Why?
|
| X Chromosome Inactivation | 1 | 2009 | 59 | 0.290 |
Why?
|
| Pregnancy Trimester, Second | 4 | 2024 | 162 | 0.280 |
Why?
|
| Pigmentation Disorders | 3 | 2010 | 22 | 0.280 |
Why?
|
| Embryonic Stem Cells | 2 | 2023 | 157 | 0.280 |
Why?
|
| Dosage Compensation, Genetic | 5 | 2001 | 54 | 0.270 |
Why?
|
| Bone Diseases, Developmental | 3 | 2010 | 64 | 0.270 |
Why?
|
| Molecular Sequence Data | 12 | 2013 | 3464 | 0.270 |
Why?
|
| Chromosomes, Human, Pair 19 | 2 | 2005 | 54 | 0.270 |
Why?
|
| Mice, Knockout | 5 | 2026 | 3819 | 0.270 |
Why?
|
| Pregnancy Complications, Neoplastic | 2 | 2009 | 60 | 0.260 |
Why?
|
| Referral and Consultation | 2 | 2025 | 564 | 0.260 |
Why?
|
| Lymphocytes | 3 | 2012 | 344 | 0.260 |
Why?
|
| Obstetrics | 1 | 2010 | 235 | 0.260 |
Why?
|
| Inheritance Patterns | 4 | 2018 | 127 | 0.260 |
Why?
|
| Nuclear Proteins | 4 | 2003 | 1211 | 0.260 |
Why?
|
| Genes, X-Linked | 1 | 2007 | 59 | 0.250 |
Why?
|
| Repressor Proteins | 5 | 2003 | 760 | 0.250 |
Why?
|
| Wnt Proteins | 1 | 2007 | 191 | 0.240 |
Why?
|
| Sequence Deletion | 2 | 2010 | 516 | 0.240 |
Why?
|
| Health Surveys | 1 | 2007 | 261 | 0.230 |
Why?
|
| Consensus | 2 | 2025 | 512 | 0.230 |
Why?
|
| Dental Enamel Proteins | 1 | 2005 | 3 | 0.230 |
Why?
|
| Lymphangioma, Cystic | 2 | 2023 | 16 | 0.230 |
Why?
|
| Facial Bones | 1 | 2005 | 31 | 0.230 |
Why?
|
| Choroid Diseases | 1 | 2005 | 17 | 0.230 |
Why?
|
| Dental Enamel | 1 | 2005 | 18 | 0.230 |
Why?
|
| Behavior, Animal | 2 | 2019 | 480 | 0.230 |
Why?
|
| Genes, Recessive | 1 | 2006 | 193 | 0.220 |
Why?
|
| Hydrops Fetalis | 2 | 2023 | 82 | 0.220 |
Why?
|
| Pedigree | 10 | 2019 | 1677 | 0.220 |
Why?
|
| Autopsy | 1 | 2025 | 111 | 0.210 |
Why?
|
| Predictive Value of Tests | 5 | 2019 | 2304 | 0.210 |
Why?
|
| Mass Screening | 2 | 2022 | 822 | 0.210 |
Why?
|
| Maternal Nutritional Physiological Phenomena | 2 | 2017 | 48 | 0.210 |
Why?
|
| Contractile Proteins | 1 | 2004 | 15 | 0.210 |
Why?
|
| Cells, Cultured | 5 | 2014 | 2885 | 0.210 |
Why?
|
| Inclusion Bodies | 1 | 2004 | 38 | 0.200 |
Why?
|
| Gene Duplication | 3 | 2018 | 358 | 0.200 |
Why?
|
| HLA-G Antigens | 1 | 2023 | 6 | 0.200 |
Why?
|
| Spasms, Infantile | 1 | 2005 | 166 | 0.200 |
Why?
|
| Bone Morphogenetic Protein 4 | 1 | 2023 | 42 | 0.200 |
Why?
|
| Activins | 1 | 2023 | 72 | 0.200 |
Why?
|
| Fibroblast Growth Factor 2 | 1 | 2023 | 48 | 0.200 |
Why?
|
| Maternal Inheritance | 1 | 2023 | 12 | 0.200 |
Why?
|
| Mice, Transgenic | 3 | 2005 | 2326 | 0.200 |
Why?
|
| Genotype | 6 | 2018 | 2595 | 0.190 |
Why?
|
| Sequence Analysis, RNA | 1 | 2026 | 407 | 0.190 |
Why?
|
| 46, XX Disorders of Sex Development | 1 | 2023 | 25 | 0.190 |
Why?
|
| Cell Separation | 2 | 2020 | 218 | 0.190 |
Why?
|
| Ribosomal Proteins | 1 | 2023 | 70 | 0.190 |
Why?
|
| Active Transport, Cell Nucleus | 1 | 2023 | 113 | 0.190 |
Why?
|
| Cell Differentiation | 3 | 2023 | 1928 | 0.180 |
Why?
|
| Whole Genome Sequencing | 2 | 2025 | 362 | 0.180 |
Why?
|
| Basal Ganglia Diseases | 1 | 2002 | 22 | 0.180 |
Why?
|
| Ligases | 1 | 2001 | 35 | 0.170 |
Why?
|
| Blood Grouping and Crossmatching | 2 | 1999 | 15 | 0.170 |
Why?
|
| Informed Consent | 2 | 2015 | 351 | 0.170 |
Why?
|
| Polydactyly | 1 | 2001 | 18 | 0.170 |
Why?
|
| Acyltransferases | 3 | 2012 | 63 | 0.170 |
Why?
|
| Young Adult | 7 | 2019 | 10103 | 0.170 |
Why?
|
| Mice, Inbred C57BL | 6 | 2018 | 4738 | 0.170 |
Why?
|
| Cells | 1 | 2021 | 20 | 0.170 |
Why?
|
| Urogenital Abnormalities | 1 | 2023 | 155 | 0.170 |
Why?
|
| Astrocytes | 1 | 2004 | 264 | 0.170 |
Why?
|
| Multifactorial Inheritance | 1 | 2022 | 176 | 0.170 |
Why?
|
| Brain Diseases | 1 | 2004 | 299 | 0.170 |
Why?
|
| Superovulation | 1 | 2020 | 11 | 0.170 |
Why?
|
| Embryo Culture Techniques | 1 | 2020 | 19 | 0.160 |
Why?
|
| Genetic Variation | 4 | 2015 | 1559 | 0.160 |
Why?
|
| Point Mutation | 4 | 2007 | 333 | 0.160 |
Why?
|
| DNA Fragmentation | 1 | 2020 | 53 | 0.160 |
Why?
|
| Chromatin | 4 | 2013 | 499 | 0.160 |
Why?
|
| Transforming Growth Factor beta | 1 | 2023 | 451 | 0.160 |
Why?
|
| Nuchal Translucency Measurement | 2 | 2019 | 18 | 0.160 |
Why?
|
| Parents | 2 | 2025 | 1128 | 0.160 |
Why?
|
| Embryo Transfer | 1 | 2020 | 48 | 0.160 |
Why?
|
| Rh Isoimmunization | 2 | 1999 | 27 | 0.160 |
Why?
|
| Hydrocephalus | 1 | 2022 | 245 | 0.160 |
Why?
|
| Meningomyelocele | 1 | 2023 | 260 | 0.150 |
Why?
|
| Protein Kinases | 1 | 2001 | 312 | 0.150 |
Why?
|
| Adolescent | 9 | 2017 | 20987 | 0.150 |
Why?
|
| Mullerian Ducts | 2 | 2023 | 44 | 0.150 |
Why?
|
| Cell Shape | 2 | 2017 | 67 | 0.150 |
Why?
|
| Microcephaly | 1 | 2022 | 347 | 0.150 |
Why?
|
| Signal Transduction | 2 | 2014 | 4686 | 0.150 |
Why?
|
| Mothers | 1 | 2023 | 388 | 0.150 |
Why?
|
| Indomethacin | 3 | 1994 | 79 | 0.150 |
Why?
|
| Reverse Transcriptase Polymerase Chain Reaction | 4 | 2007 | 1205 | 0.150 |
Why?
|
| Maternal Behavior | 1 | 2019 | 66 | 0.150 |
Why?
|
| Erythroblastosis, Fetal | 2 | 1999 | 27 | 0.150 |
Why?
|
| Introns | 3 | 2012 | 278 | 0.140 |
Why?
|
| RNA Helicases | 1 | 2019 | 73 | 0.140 |
Why?
|
| CpG Islands | 2 | 2013 | 337 | 0.140 |
Why?
|
| Chromosome Mapping | 6 | 2005 | 1046 | 0.140 |
Why?
|
| DEAD-box RNA Helicases | 1 | 2019 | 160 | 0.140 |
Why?
|
| Zinc Fingers | 1 | 1998 | 116 | 0.130 |
Why?
|
| Uterine Diseases | 1 | 1998 | 22 | 0.130 |
Why?
|
| Diffusion Tensor Imaging | 1 | 2019 | 255 | 0.130 |
Why?
|
| Mutation, Missense | 3 | 2019 | 919 | 0.130 |
Why?
|
| Genome | 1 | 2019 | 451 | 0.130 |
Why?
|
| Fertilization | 1 | 2017 | 44 | 0.130 |
Why?
|
| Maternal Serum Screening Tests | 1 | 2016 | 3 | 0.120 |
Why?
|
| Genetic Predisposition to Disease | 4 | 2022 | 3436 | 0.120 |
Why?
|
| Liver | 2 | 2017 | 1796 | 0.120 |
Why?
|
| Androgens | 1 | 2018 | 247 | 0.120 |
Why?
|
| Risk Assessment | 2 | 2018 | 3711 | 0.120 |
Why?
|
| Gene Expression | 2 | 2017 | 1481 | 0.120 |
Why?
|
| Genotyping Techniques | 1 | 2016 | 110 | 0.120 |
Why?
|
| Infant | 9 | 2019 | 13352 | 0.110 |
Why?
|
| Body Mass Index | 2 | 2020 | 1717 | 0.110 |
Why?
|
| Risk Factors | 4 | 2018 | 11074 | 0.110 |
Why?
|
| Hypothalamus | 1 | 2017 | 206 | 0.110 |
Why?
|
| Virus Diseases | 1 | 1998 | 285 | 0.110 |
Why?
|
| Neoplasm Proteins | 1 | 2019 | 680 | 0.110 |
Why?
|
| Diet | 1 | 2002 | 1121 | 0.110 |
Why?
|
| Biomarkers | 2 | 2022 | 3385 | 0.110 |
Why?
|
| Confidentiality | 1 | 2015 | 108 | 0.110 |
Why?
|
| Child | 10 | 2014 | 26341 | 0.110 |
Why?
|
| Child, Preschool | 7 | 2023 | 15110 | 0.100 |
Why?
|
| Protein Binding | 2 | 2017 | 1652 | 0.100 |
Why?
|
| Purpura, Thrombocytopenic | 1 | 1994 | 6 | 0.100 |
Why?
|
| Antigens, Human Platelet | 1 | 1994 | 6 | 0.100 |
Why?
|
| Obstetric Labor, Premature | 2 | 1993 | 76 | 0.100 |
Why?
|
| Reproductive Health Services | 1 | 2014 | 24 | 0.100 |
Why?
|
| Cyclooxygenase Inhibitors | 2 | 1994 | 47 | 0.100 |
Why?
|
| Hippocampus | 1 | 2019 | 806 | 0.100 |
Why?
|
| Class I Phosphatidylinositol 3-Kinases | 1 | 2014 | 77 | 0.100 |
Why?
|
| Cell Line | 3 | 2016 | 2552 | 0.100 |
Why?
|
| Practice Patterns, Physicians' | 1 | 2020 | 789 | 0.100 |
Why?
|
| Adipose Tissue | 1 | 2017 | 502 | 0.100 |
Why?
|
| Infertility, Female | 1 | 2014 | 145 | 0.100 |
Why?
|
| Chromosomes, Human, Pair 12 | 1 | 1993 | 91 | 0.100 |
Why?
|
| Cell Lineage | 2 | 2013 | 349 | 0.100 |
Why?
|
| Wnt Signaling Pathway | 1 | 2014 | 223 | 0.100 |
Why?
|
| Ductus Arteriosus | 1 | 1993 | 59 | 0.090 |
Why?
|
| Neurodevelopmental Disorders | 1 | 2019 | 629 | 0.090 |
Why?
|
| Sensitivity and Specificity | 4 | 2010 | 2085 | 0.090 |
Why?
|
| Pregnancy Complications, Infectious | 1 | 1998 | 514 | 0.090 |
Why?
|
| Abnormal Karyotype | 1 | 2012 | 8 | 0.090 |
Why?
|
| Wnt3A Protein | 1 | 2012 | 10 | 0.090 |
Why?
|
| Gene Knockdown Techniques | 1 | 2013 | 378 | 0.090 |
Why?
|
| Breeding | 1 | 2012 | 19 | 0.090 |
Why?
|
| Pupil Disorders | 1 | 2012 | 18 | 0.090 |
Why?
|
| Induced Pluripotent Stem Cells | 1 | 2014 | 238 | 0.090 |
Why?
|
| Multicenter Studies as Topic | 2 | 2023 | 294 | 0.090 |
Why?
|
| Chromosomes, Human, Pair 17 | 1 | 1994 | 363 | 0.090 |
Why?
|
| Chimera | 1 | 2012 | 79 | 0.090 |
Why?
|
| Patient Satisfaction | 1 | 2015 | 464 | 0.090 |
Why?
|
| Gene Knockout Techniques | 1 | 2012 | 133 | 0.090 |
Why?
|
| Eye Abnormalities | 1 | 2012 | 105 | 0.090 |
Why?
|
| Gene Silencing | 1 | 2012 | 229 | 0.080 |
Why?
|
| Gene Targeting | 1 | 2012 | 169 | 0.080 |
Why?
|
| Metagenome | 1 | 2012 | 138 | 0.080 |
Why?
|
| Mediator Complex | 1 | 2011 | 62 | 0.080 |
Why?
|
| Metagenomics | 1 | 2012 | 116 | 0.080 |
Why?
|
| RNA, Messenger | 4 | 2006 | 2550 | 0.080 |
Why?
|
| Optic Nerve Diseases | 1 | 2012 | 76 | 0.080 |
Why?
|
| Twins | 1 | 1991 | 70 | 0.080 |
Why?
|
| Pregnancy, Multiple | 1 | 1991 | 44 | 0.080 |
Why?
|
| Femur Head Necrosis | 1 | 1990 | 8 | 0.080 |
Why?
|
| Fibroblasts | 1 | 2014 | 849 | 0.080 |
Why?
|
| Vagina | 1 | 2012 | 208 | 0.080 |
Why?
|
| Molecular Diagnostic Techniques | 1 | 2011 | 166 | 0.080 |
Why?
|
| Cardiotocography | 1 | 2010 | 20 | 0.080 |
Why?
|
| Hyperammonemia | 1 | 2010 | 59 | 0.080 |
Why?
|
| Sex Chromosome Disorders | 1 | 2009 | 9 | 0.080 |
Why?
|
| Family Health | 3 | 2007 | 240 | 0.080 |
Why?
|
| Pheochromocytoma | 1 | 2009 | 31 | 0.080 |
Why?
|
| von Hippel-Lindau Disease | 1 | 2009 | 22 | 0.070 |
Why?
|
| Adrenal Gland Neoplasms | 1 | 2009 | 64 | 0.070 |
Why?
|
| Gene Expression Regulation | 3 | 2011 | 2323 | 0.070 |
Why?
|
| Prognosis | 1 | 2018 | 4886 | 0.070 |
Why?
|
| Egypt | 1 | 2007 | 33 | 0.070 |
Why?
|
| Heterozygote | 1 | 2010 | 737 | 0.070 |
Why?
|
| Ubiquitin-Protein Ligases | 2 | 2001 | 354 | 0.060 |
Why?
|
| Epididymis | 1 | 1988 | 62 | 0.060 |
Why?
|
| Varicocele | 1 | 1988 | 60 | 0.060 |
Why?
|
| Cell Cycle Proteins | 1 | 2011 | 710 | 0.060 |
Why?
|
| Microsatellite Repeats | 2 | 2005 | 204 | 0.060 |
Why?
|
| DNA Primers | 3 | 1998 | 599 | 0.060 |
Why?
|
| Foot Deformities, Congenital | 2 | 2010 | 16 | 0.060 |
Why?
|
| Case-Control Studies | 1 | 2013 | 3359 | 0.060 |
Why?
|
| Disease Management | 1 | 2010 | 558 | 0.060 |
Why?
|
| Proteoglycans | 1 | 2006 | 77 | 0.060 |
Why?
|
| Sleep Apnea, Obstructive | 1 | 2010 | 245 | 0.060 |
Why?
|
| Nucleic Acid Hybridization | 1 | 2006 | 295 | 0.060 |
Why?
|
| Clone Cells | 1 | 2006 | 153 | 0.060 |
Why?
|
| Mutant Proteins | 1 | 2006 | 111 | 0.060 |
Why?
|
| Receptors, Androgen | 1 | 2009 | 408 | 0.060 |
Why?
|
| Amelogenesis Imperfecta | 1 | 2005 | 1 | 0.060 |
Why?
|
| Amelogenin | 1 | 2005 | 3 | 0.060 |
Why?
|
| Tooth | 1 | 2005 | 16 | 0.060 |
Why?
|
| Hand Deformities, Congenital | 2 | 2010 | 96 | 0.060 |
Why?
|
| Microscopy, Electron, Scanning | 1 | 2005 | 115 | 0.060 |
Why?
|
| Microscopy, Electron, Transmission | 1 | 2005 | 129 | 0.060 |
Why?
|
| Blotting, Northern | 2 | 2003 | 234 | 0.060 |
Why?
|
| Infertility, Male | 1 | 1988 | 296 | 0.050 |
Why?
|
| Pregnancy Trimester, Third | 2 | 1998 | 122 | 0.050 |
Why?
|
| Delphi Technique | 1 | 2025 | 283 | 0.050 |
Why?
|
| Genes, Essential | 1 | 2024 | 39 | 0.050 |
Why?
|
| Promoter Regions, Genetic | 2 | 2004 | 1207 | 0.050 |
Why?
|
| Filamins | 1 | 2004 | 26 | 0.050 |
Why?
|
| Gene Library | 1 | 2004 | 212 | 0.050 |
Why?
|
| Corpus Callosum | 1 | 2004 | 104 | 0.050 |
Why?
|
| Survival Analysis | 1 | 2007 | 1483 | 0.050 |
Why?
|
| Texas | 1 | 2012 | 3686 | 0.050 |
Why?
|
| Totipotent Stem Cells | 1 | 2002 | 2 | 0.050 |
Why?
|
| Holoenzymes | 1 | 2002 | 14 | 0.050 |
Why?
|
| Socioeconomic Factors | 1 | 2026 | 915 | 0.050 |
Why?
|
| 5' Untranslated Regions | 1 | 2002 | 58 | 0.050 |
Why?
|
| Sequence Homology, Nucleic Acid | 1 | 2002 | 252 | 0.050 |
Why?
|
| Prospective Studies | 3 | 2025 | 6459 | 0.050 |
Why?
|
| Human Development | 1 | 2002 | 6 | 0.040 |
Why?
|
| Cloning, Molecular | 2 | 2004 | 780 | 0.040 |
Why?
|
| Cohort Studies | 3 | 2016 | 5063 | 0.040 |
Why?
|
| Attitude | 1 | 2022 | 111 | 0.040 |
Why?
|
| Transgenes | 1 | 2002 | 316 | 0.040 |
Why?
|
| Family | 2 | 2018 | 589 | 0.040 |
Why?
|
| Crosses, Genetic | 1 | 2001 | 152 | 0.040 |
Why?
|
| Blotting, Southern | 1 | 2001 | 203 | 0.040 |
Why?
|
| Stochastic Processes | 1 | 2001 | 35 | 0.040 |
Why?
|
| Seizures | 1 | 2007 | 890 | 0.040 |
Why?
|
| Recurrence | 1 | 2005 | 1489 | 0.040 |
Why?
|
| DNA, Complementary | 2 | 1999 | 422 | 0.040 |
Why?
|
| Mice, Mutant Strains | 1 | 2001 | 356 | 0.040 |
Why?
|
| Diseases in Twins | 1 | 2001 | 86 | 0.040 |
Why?
|
| Attention | 1 | 2022 | 194 | 0.040 |
Why?
|
| Kruppel-Like Transcription Factors | 1 | 2001 | 111 | 0.040 |
Why?
|
| Homozygote | 1 | 2022 | 533 | 0.040 |
Why?
|
| Academic Medical Centers | 1 | 2022 | 321 | 0.040 |
Why?
|
| Selection, Genetic | 1 | 2001 | 150 | 0.040 |
Why?
|
| Disease Progression | 1 | 2007 | 2200 | 0.040 |
Why?
|
| Fibroma | 1 | 2000 | 29 | 0.040 |
Why?
|
| Cell Survival | 1 | 2002 | 826 | 0.040 |
Why?
|
| Age Factors | 1 | 2007 | 2825 | 0.040 |
Why?
|
| Calcinosis | 1 | 2002 | 180 | 0.040 |
Why?
|
| Counseling | 1 | 2022 | 238 | 0.040 |
Why?
|
| Reproducibility of Results | 2 | 2016 | 2904 | 0.040 |
Why?
|
| Folic Acid | 1 | 2002 | 269 | 0.040 |
Why?
|
| Thanatophoric Dysplasia | 1 | 2019 | 5 | 0.040 |
Why?
|
| Achondroplasia | 1 | 2019 | 24 | 0.040 |
Why?
|
| Uterus | 1 | 2023 | 541 | 0.040 |
Why?
|
| False Negative Reactions | 1 | 1999 | 89 | 0.040 |
Why?
|
| Karyotype | 1 | 2018 | 30 | 0.040 |
Why?
|
| Acrocephalosyndactylia | 1 | 2019 | 25 | 0.040 |
Why?
|
| De Lange Syndrome | 1 | 2019 | 44 | 0.040 |
Why?
|
| Collagen Type I | 1 | 2019 | 110 | 0.040 |
Why?
|
| Physical Chromosome Mapping | 1 | 1998 | 55 | 0.040 |
Why?
|
| Tissue Array Analysis | 1 | 2018 | 136 | 0.040 |
Why?
|
| Genes, Regulator | 1 | 1998 | 44 | 0.040 |
Why?
|
| United States | 1 | 2014 | 12072 | 0.030 |
Why?
|
| Neural Tube Defects | 1 | 2002 | 330 | 0.030 |
Why?
|
| Chromosomes | 1 | 2018 | 120 | 0.030 |
Why?
|
| RNA Virus Infections | 1 | 1998 | 7 | 0.030 |
Why?
|
| Radiography | 2 | 2010 | 743 | 0.030 |
Why?
|
| Fluorescent Antibody Technique | 1 | 2018 | 410 | 0.030 |
Why?
|
| DNA Virus Infections | 1 | 1998 | 22 | 0.030 |
Why?
|
| Skin | 1 | 2001 | 545 | 0.030 |
Why?
|
| Cri-du-Chat Syndrome | 1 | 2017 | 4 | 0.030 |
Why?
|
| Sex Chromosome Disorders of Sex Development | 1 | 2017 | 15 | 0.030 |
Why?
|
| Klinefelter Syndrome | 1 | 2017 | 20 | 0.030 |
Why?
|
| Trisomy 13 Syndrome | 1 | 2017 | 20 | 0.030 |
Why?
|
| Trisomy 18 Syndrome | 1 | 2017 | 17 | 0.030 |
Why?
|
| Species Specificity | 1 | 1998 | 470 | 0.030 |
Why?
|
| Organ Specificity | 1 | 1998 | 394 | 0.030 |
Why?
|
| Mammals | 1 | 2018 | 253 | 0.030 |
Why?
|
| Trisomy | 1 | 2017 | 111 | 0.030 |
Why?
|
| Angelman Syndrome | 1 | 2017 | 68 | 0.030 |
Why?
|
| Prader-Willi Syndrome | 1 | 2017 | 62 | 0.030 |
Why?
|
| Gene Expression Regulation, Neoplastic | 1 | 2004 | 2026 | 0.030 |
Why?
|
| Contraindications | 2 | 1994 | 75 | 0.030 |
Why?
|
| Pregnancy, High-Risk | 1 | 2016 | 39 | 0.030 |
Why?
|
| Brain | 1 | 2008 | 3175 | 0.030 |
Why?
|
| Intellectual Disability | 1 | 2004 | 1089 | 0.030 |
Why?
|
| Bone and Bones | 1 | 2019 | 308 | 0.030 |
Why?
|
| Alternative Splicing | 1 | 1998 | 307 | 0.030 |
Why?
|
| Osteogenesis Imperfecta | 1 | 2019 | 182 | 0.030 |
Why?
|
| Electrophoresis, Agar Gel | 1 | 1996 | 39 | 0.030 |
Why?
|
| Diagnosis, Differential | 1 | 2002 | 1882 | 0.030 |
Why?
|
| Delivery of Health Care | 1 | 2022 | 689 | 0.030 |
Why?
|
| Healthy Volunteers | 1 | 2016 | 154 | 0.030 |
Why?
|
| Fathers | 1 | 1996 | 74 | 0.030 |
Why?
|
| Genetic Association Studies | 1 | 2019 | 819 | 0.030 |
Why?
|
| Magnetic Resonance Imaging | 2 | 2022 | 3763 | 0.030 |
Why?
|
| Chromosome Deletion | 1 | 2018 | 653 | 0.030 |
Why?
|
| Blastomeres | 1 | 1995 | 6 | 0.030 |
Why?
|
| Israel | 1 | 2015 | 44 | 0.030 |
Why?
|
| Drosophila | 1 | 1999 | 739 | 0.030 |
Why?
|
| Abdominal Muscles | 1 | 1995 | 28 | 0.030 |
Why?
|
| Fetal Monitoring | 2 | 1994 | 59 | 0.030 |
Why?
|
| Iatrogenic Disease | 1 | 1995 | 121 | 0.030 |
Why?
|
| Polyhydramnios | 1 | 1994 | 52 | 0.030 |
Why?
|
| Cell Transdifferentiation | 1 | 2014 | 57 | 0.030 |
Why?
|
| Integrin beta3 | 1 | 1994 | 27 | 0.030 |
Why?
|
| Dystrophin | 1 | 1994 | 39 | 0.030 |
Why?
|
| Transduction, Genetic | 1 | 2014 | 276 | 0.030 |
Why?
|
| Isoantibodies | 1 | 1994 | 59 | 0.030 |
Why?
|
| Alleles | 1 | 2018 | 1673 | 0.030 |
Why?
|
| Drosophila Proteins | 1 | 1999 | 718 | 0.020 |
Why?
|
| Risk | 1 | 2015 | 726 | 0.020 |
Why?
|
| Feasibility Studies | 1 | 2016 | 824 | 0.020 |
Why?
|
| Diastole | 1 | 1993 | 181 | 0.020 |
Why?
|
| Amino Acid Sequence | 3 | 2003 | 2395 | 0.020 |
Why?
|
| Constriction, Pathologic | 1 | 1993 | 221 | 0.020 |
Why?
|
| Surveys and Questionnaires | 2 | 2015 | 4066 | 0.020 |
Why?
|
| Blood Flow Velocity | 1 | 1993 | 417 | 0.020 |
Why?
|
| Oligonucleotide Probes | 1 | 2012 | 84 | 0.020 |
Why?
|
| Regression Analysis | 1 | 1993 | 761 | 0.020 |
Why?
|
| Forecasting | 1 | 1993 | 351 | 0.020 |
Why?
|
| Williams Syndrome | 1 | 2012 | 42 | 0.020 |
Why?
|
| L-Lactate Dehydrogenase | 1 | 2011 | 59 | 0.020 |
Why?
|
| Blotting, Western | 2 | 2003 | 1013 | 0.020 |
Why?
|
| Ultrasonography | 2 | 1993 | 943 | 0.020 |
Why?
|
| Alanine Transaminase | 1 | 2011 | 153 | 0.020 |
Why?
|
| Tissue Distribution | 2 | 2003 | 358 | 0.020 |
Why?
|
| Lung Diseases | 1 | 1995 | 398 | 0.020 |
Why?
|
| Tomography, Emission-Computed | 1 | 1990 | 35 | 0.020 |
Why?
|
| DNA, Bacterial | 1 | 2012 | 481 | 0.020 |
Why?
|
| RNA Splice Sites | 1 | 2010 | 92 | 0.020 |
Why?
|
| Pilot Projects | 1 | 2014 | 1445 | 0.020 |
Why?
|
| Lactation | 1 | 2011 | 195 | 0.020 |
Why?
|
| Hernias, Diaphragmatic, Congenital | 1 | 1995 | 401 | 0.020 |
Why?
|
| Charcot-Marie-Tooth Disease | 1 | 2012 | 227 | 0.020 |
Why?
|
| Genetic Heterogeneity | 1 | 2010 | 132 | 0.020 |
Why?
|
| Codon, Nonsense | 1 | 2010 | 136 | 0.020 |
Why?
|
| Follow-Up Studies | 2 | 2010 | 5196 | 0.020 |
Why?
|
| Lod Score | 2 | 2000 | 126 | 0.020 |
Why?
|
| Algorithms | 1 | 1996 | 1680 | 0.020 |
Why?
|
| Heart Rate, Fetal | 1 | 2010 | 62 | 0.020 |
Why?
|
| Periventricular Nodular Heterotopia | 1 | 2008 | 8 | 0.020 |
Why?
|
| Central Nervous System Cysts | 1 | 2008 | 12 | 0.020 |
Why?
|
| Polysomnography | 1 | 2010 | 153 | 0.020 |
Why?
|
| Sequence Homology, Amino Acid | 2 | 1999 | 623 | 0.020 |
Why?
|
| Malformations of Cortical Development | 1 | 2008 | 60 | 0.020 |
Why?
|
| Palpation | 1 | 1988 | 18 | 0.020 |
Why?
|
| Bacteria | 1 | 2012 | 521 | 0.020 |
Why?
|
| Testicular Diseases | 1 | 1988 | 12 | 0.020 |
Why?
|
| Haplotypes | 2 | 2000 | 519 | 0.020 |
Why?
|
| Body Weight | 1 | 2011 | 987 | 0.020 |
Why?
|
| Chromosome Banding | 1 | 2006 | 135 | 0.020 |
Why?
|
| Multivariate Analysis | 1 | 2010 | 1378 | 0.020 |
Why?
|
| Chromosomes, Human, Pair 3 | 1 | 2006 | 89 | 0.020 |
Why?
|
| Breast | 1 | 1988 | 215 | 0.020 |
Why?
|
| Patient Selection | 1 | 2010 | 729 | 0.010 |
Why?
|
| Muscle, Skeletal | 1 | 2011 | 981 | 0.010 |
Why?
|
| Leukemia, Experimental | 1 | 2004 | 16 | 0.010 |
Why?
|
| Deoxyribonucleases, Type II Site-Specific | 1 | 2004 | 47 | 0.010 |
Why?
|
| Restriction Mapping | 1 | 2004 | 167 | 0.010 |
Why?
|
| Luciferases | 1 | 2004 | 127 | 0.010 |
Why?
|
| Interleukin-15 | 1 | 2004 | 104 | 0.010 |
Why?
|
| Cyclin-Dependent Kinase Inhibitor p57 | 1 | 2003 | 13 | 0.010 |
Why?
|
| Precipitin Tests | 1 | 2003 | 109 | 0.010 |
Why?
|
| Xenopus Proteins | 1 | 2003 | 55 | 0.010 |
Why?
|
| Xenopus laevis | 1 | 2003 | 112 | 0.010 |
Why?
|
| Placentation | 1 | 2003 | 59 | 0.010 |
Why?
|
| Tubulin | 1 | 2003 | 76 | 0.010 |
Why?
|
| Glutathione Transferase | 1 | 2003 | 148 | 0.010 |
Why?
|
| Models, Animal | 1 | 2004 | 450 | 0.010 |
Why?
|
| In Situ Hybridization | 1 | 2003 | 437 | 0.010 |
Why?
|
| Protein Structure, Tertiary | 1 | 2003 | 716 | 0.010 |
Why?
|
| Receptors, Notch | 1 | 2003 | 197 | 0.010 |
Why?
|
| Lymphoma | 1 | 2004 | 327 | 0.010 |
Why?
|
| Decision Making | 1 | 2006 | 726 | 0.010 |
Why?
|
| Models, Genetic | 1 | 2003 | 749 | 0.010 |
Why?
|
| Immunohistochemistry | 1 | 2003 | 1591 | 0.010 |
Why?
|
| Electrophysiology | 1 | 2000 | 241 | 0.010 |
Why?
|
| Histones | 1 | 2003 | 541 | 0.010 |
Why?
|
| Recombination, Genetic | 1 | 2000 | 422 | 0.010 |
Why?
|
| Transcription, Genetic | 1 | 2003 | 1363 | 0.010 |
Why?
|
| Models, Biological | 1 | 2003 | 1371 | 0.010 |
Why?
|
| Polymorphism, Genetic | 1 | 2000 | 776 | 0.010 |
Why?
|
| Binding Sites | 1 | 1999 | 1133 | 0.010 |
Why?
|
| Breast Neoplasms | 1 | 1988 | 2602 | 0.010 |
Why?
|
| Embryonic and Fetal Development | 1 | 1995 | 117 | 0.010 |
Why?
|
| Hernia, Diaphragmatic | 1 | 1995 | 91 | 0.010 |
Why?
|
| Sheep | 1 | 1995 | 229 | 0.010 |
Why?
|
| Sex Determination Analysis | 1 | 1994 | 15 | 0.010 |
Why?
|
| Organ Size | 1 | 1995 | 407 | 0.010 |
Why?
|
| Muscular Dystrophies | 1 | 1994 | 51 | 0.010 |
Why?
|
| Neurons | 1 | 2003 | 1979 | 0.010 |
Why?
|
| Time Factors | 1 | 2003 | 6196 | 0.010 |
Why?
|
| Gene Amplification | 1 | 1994 | 219 | 0.010 |
Why?
|
| Severity of Illness Index | 1 | 2000 | 3061 | 0.010 |
Why?
|
| Fibrocystic Breast Disease | 1 | 1988 | 7 | 0.000 |
Why?
|
| Thermography | 1 | 1988 | 12 | 0.000 |
Why?
|
| Mammography | 1 | 1988 | 122 | 0.000 |
Why?
|
| Lung | 1 | 1995 | 1535 | 0.000 |
Why?
|
| Physical Examination | 1 | 1988 | 171 | 0.000 |
Why?
|
| Middle Aged | 1 | 1988 | 28601 | 0.000 |
Why?
|